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Caspase-8 Is Required for Cell Death Induced
by Expanded Polyglutamine Repeats
form aggregates or inclusions, as has been observed in
cultured cells overexpressing a truncated ataxin-3 (the
product of the SCA3 gene) with an expanded polyglu-
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tamine tract (Ikeda et al., 1996), in transgenic mice ex-*Department of Cell Biology
pressing a truncated huntingtin (the product of the HDHarvard Medical School
gene) (Bates and Davies, 1997), in Drosophila express-Boston, Massachusetts 02115
ing a truncated ataxin-3 (Warrick et al., 1998), and in²The Fourth Department
postmortem brains of individuals with SCA3 or HD (DiFi-Osaka Biosciences Institute
glia et al., 1997; Paulson et al., 1997). Although it hasOsaka 565±0874
been proposed that such abnormal inclusions partici-Japan
pate in inappropriate protein±protein interactions that
lead to cell death, the nature of such interactions and
the mechanism by which cell death is induced remainSummary
unclear.
Mammalian apoptosis is regulated by evolutionarilyWe show here that caspase-8 is required for the death
conserved pathways whose critical components are ho-of primary rat neurons induced by an expanded poly-
mologs of those that mediate programmed cell death inglutamine repeat (Q79). Expression of Q79 recruited and
the nematode Caenorhabditis elegans (Cryns and Yuan,activated caspase-8. Inhibition of caspase-8 blocked
1998). The members of the mammalian Bcl-2 family ofpolyglutamine-induced cell death. Coexpression of Q79
proteins are homologs of CED-9, which suppresses cellwith the caspase inhibitor CrmA, a dominant-negative
death in C. elegans. Expression of Bcl-2 or Bcl-xL, twomutant of FADD (FADD DN), Bcl-2, or Bcl-xL, but not
major anti-apoptotic members of the family, inhibitsan N-terminally tagged Bcl-xL, prevented the recruit-
apoptosis induced by many different stimuli. Mamma-ment of caspase-8 and inhibited polyglutamine-induced
lian caspases are homologs of the product of the C.cell death. Furthermore, Western blot analysis re-
elegans cell death gene ced-3 and play important rolesvealed the presence of activated caspase-8 in the in-
in regulating apoptosis (Cryns and Yuan, 1998). A cyto-soluble fraction of affected brain regions from Hun-
kine response±modifier gene (crmA) of cowpox virustington's disease (HD) patients but not in those from
encodes a serpin that is a specific inhibitor of two mam-neurologically unremarkable controls, suggesting the
malian caspases, caspase-1 and caspase-8 (Zhou et al.,relocation and activation of caspase-8 during the patho-
1997). Two polyglutamine-containing proteins, hunting-genesis of HD. These results suggest an essential role
tin and the DRPLA, are indeed cleaved by caspasesof caspase-8 in HD-related neural degenerative dis-
during apoptosis, observations that have led to the hy-eases.
pothesis that caspases may be responsible for cleavage
of the mutant proteins containing expanded polygluta-Introduction
mine tracts and the generation of toxic protein frag-
ments in vivo (Goldberg et al., 1996; Miyashita et al.,Expansion of CAG trinucleotide repeats that encode
1997; Wellington et al., 1998). However, a critical rolepolyglutamine tracts in otherwise unrelated proteins is
for caspases in the generation of such toxic proteinnow known to be the underlying cause of eight neurode-
fragments, or a possible role for these enzymes aftergenerative diseases, including Huntington's disease
the initial cleavage event, remains to be demonstrated.
(HD) and spinocerebellar ataxia 3 (Huntington's Disease
The Fas pathway of apoptosis plays an important role
Collaborative Research Group, 1993; Kawaguchi et al.,
in the immune system, contributing to cytotoxic T lym-
1994). Such expansion of polyglutamine repeats ap- phocyte±mediated cytotoxicity and downregulation of
pears to constitute a toxic gain-of-function mutation immune responses. Activation of the Fas pathway by
that is selectively deleterious to the neurons affected in Fas ligand or agonistic antibodies induces oligomer-
these diseases (Paulson and Fischbeck, 1996). Expres- ization of the Fas receptor, which results in exposure
sion of cDNAs that encode truncated polypeptides con- of its intracellular protein±protein interaction domain,
stituting mostly the expanded polyglutamine repeats, known as the death domain, and in the formation of
but not of those that encode the corresponding full- death-inducing signaling complex (DISC), which trans-
length proteins, has been shown to induce cell death duces the Fas death signal (Kischkel et al., 1995). The
by apoptosis (Ikeda et al., 1996; Davies et al., 1997). death domain of the Fas receptor thus interacts with and
These observations have led to the hypothesis that a recruits Fas/APO-1±associated death domain protein
protein fragment derived from the full-length protein as- (FADD), an adapter protein that contains a death domain
sociated with each of these diseases may adopt a con- in its C-terminal half and another protein±protein interac-
formation that is toxic to neurons (Trottier et al., 1995) tion domain, termed the death effector domain, in its
and thereby result in neuronal degeneration (DiFiglia et N-terminal half (Chinnaiyan et al., 1995). FADD, in turn,
al., 1997). Such truncated proteins have been shown to recruits caspase-8, which contains two death effector
domains in its N-terminal region and a caspase domain
in its C-terminal region. Expression of a truncated FADD³ To whom correspondence should be addressed (e-mail: jyuan@
hms.harvard.edu). (FADD DN) containing only the C-terminal death domain
Neuron
624
has been shown to inhibit Fas-induced cell death (Chin- To determine whether caspases play a role in polyglu-
tamine-induced cell death, we investigated the effect ofnaiyan et al., 1996).
cotransfecting primary cultured neurons with expres-Given the importance of caspases in mammalian apo-
sion constructs encoding Q79 and CrmA, a cowpox virusptosis, we have investigated the role of these enzymes
serpin that is a specific inhibitor of caspases. Expressionin polyglutamine-induced cell death. We now show that
of CrmA inhibited Q79-induced cell death in all threecaspase-8 is recruited and activated by expanded poly-
types of neurons (Figures 1C and 1D), suggesting thatglutamine repeats in cultured cells and primary neurons
caspases contribute to the death program activated byand that inhibition of caspase-8 recruitment and acti-
polyglutamine repeats. The role of caspase activity invation blocks the cell death induced by these poly-
Q79-induced neuronal death was also examined byglutamine repeats. Furthermore, we provide preliminary
transfecting neurons with the Q79 vector in the absenceevidence for the contribution of caspase-8 to the patho-
or presence of 100 mM zVAD.fmk, a synthetic peptidegenesis of HD in vivo.
inhibitor of caspases. The survival of the transfected
neurons was markedly increased by the presence ofResults
zVAD.fmk (Figure 1C, top panel), again suggesting that
caspase activity is required for polyglutamine-inducedInhibition of Polyglutamine Repeat±Induced
cell death.Cell Death by Bcl-2, CrmA, and FADD DN
Fas-induced apoptosis is one of the best understoodTo investigate the mechanism by which polyglutamine
pathways of programmed cell death. We therefore in-inclusions induce cell death, we developed a transient
vestigated whether the Fas apoptotic pathway plays atransfection system whereby primary neurons were en-
role in neuronal cell death induced by polyglutaminegineered to express green fluorescent protein (GFP) and
repeats. We examined the effect of FADD DN, a domi-one of four different versions of ataxin-3. We first estab-
nant-negative inhibitor of Fas-induced apoptosis, onlished cultures of primary cortical, striatal, and cerebel-
polyglutamine repeat±induced neuronal death by co-lar neurons from embryonic day 17 (E17) rat embryos
transfecting cultures of striatal, cerebellar, or corticalin serum-free medium as described by Brewer (1995).
neurons with vectors encoding Q79 and FADD DN.We then transfected the cultured neurons with a GFP
FADD DN markedly inhibited Q79-induced cell death,vector and expression constructs encoding truncated
as assessed 48 hr after transfection, suggesting thatataxin-3 that contained either 35 (Q35) or 79 (Q79) gluta-
mediators of the Fas pathway may contribute to thismine residues (Igarashi et al., 1998). Expression of Q79,
process (Figures 1C and 1D).but not of Q35, induced cell death in the cultured striatal
Thus, three different types of apoptosis inhibitors,and cerebellar neurons and, to a lesser extent, in the
Bcl-2, CrmA, and FADD DN, all inhibited polyglutaminecortical neurons (Figures 1A and 1C, bottom panel). Neu-
repeat±induced neuronal cell death. Coexpression ofrons expressing Q79 show cell body shrinkage and chro-
Bcl-2, CrmA, or FADD DN not only prevented the cellmosomal DNA condensation (Figure 1B). Given that both
death induced by Q79 but also preserved the extensiveQ79 and Q35 expression constructs encode only 21
neurites of the cultured neurons (Figures 1B and 1D). In
amino acid residues (nine of which are the hemagglutinin
contrast, although Bcl-2 and CrmA each inhibit neuronal
[HA] tag), in addition to the polyglutamine tract, its prod-
cell death induced by trophic factor deprivation, they do
uct is essentially a polyglutamine peptide, and our re-
not prevent the loss of neurites associated with trophic
sults should be relevant to HD and other polyglutamine factor removal (Allsopp et al., 1993; Gagliardini et al.,
expansion diseases, including SCA3. 1994; see also Figure 1B). Our data thus indicate that
Because anti-apoptotic members of the Bcl-2 family Bcl-2, CrmA, and FADD DN may preserve neuronal func-
are potent inhibitors of apoptosis in a variety of systems, tion in addition to preventing cell death in neurons ex-
we examined whether expression of Bcl-2 or Bcl-xL in- pressing polyglutamine repeats.
hibits cell death induced by Q79. Cerebellar neurons Although polyglutamine repeat±induced cell death in
were transfected with the GFP vector as well as with primary neuronal cultures most closely resembles the
expression constructs encoding Q79, Q79, and Bcl-2; neuronal degeneration apparent in individuals with poly-
Q79 and Bcl-xL; or Q79 and Bcl-xL tagged at its N termi- glutamine expansion diseases, it is difficult to obtain
nus with the Flag-epitope (N-Bcl-xL). Forty-eight hours large numbers of transfected neurons for biochemical
after transfection, the percentage of cell death was de- analysis. Given that expression of polyglutamine repeats
termined by counting the numbers of dead (those has been shown to induce cell death in established cell
rounded or shrunken without processes) or live (those lines, including COS-7 and 293T cells (Paulson et al.,
with extensive processes) GFP-positive neurons. In 1997; Igarashi et al., 1998), we analyzed a similar trans-
some experiments, uptakes of propidium iodide and fection system with cell lines. We cotransfected HeLa
trypan blue were used to confirm the counting of dead cells with constructs encoding either 35 or 79 polyglu-
cells, and staining with Hoechst dye was used to monitor tamine repeats of ataxin-3 and a GFP marker. Forty-
apoptotic nuclear morphology. Expression of Bcl-2 or eight hours after transfection, the percentage of cell
Bcl-xL inhibited neuronal cell death induced by Q79 (Fig- death was determined by counting the numbers of round
ures 1B and 1C). In contrast, N-Bcl-xL, which markedly (dead) versus flat (live) GFP-positive cells. Similar to the
inhibits induction of apoptosis by the proapoptotic Bcl-2 results obtained with the primary neurons, Q79, but not
family member Bid (Li et al., 1998), had no effect on Q35, induced apoptosis in HeLa cells (Figure 1E, left
cell death triggered by Q79 (Figures 1C and 1E). These panel). Furthermore, coexpression of CrmA, FADD DN,
results suggest that a free N terminus is required for Bcl-2, or Bcl-xL, but not N-Bcl-xL, inhibited Q79-induced
HeLa cell death (Figure 1E, middle panel). Although asBcl-xL to inhibit polyglutamine repeat±induced cell death.
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Figure 1. Induction of Cell Death by Q79 and
Its Inhibition by CrmA, FADD DN, Bcl-2, and
Bcl-xL in Primary Neurons and HeLa Cells
(A) Induction of cell death in primary neurons
by expression of Q79 but not by that of Q35.
Cultures of cerebellar and striatal neurons
from E17 rat embryos were transfected with
both a vector encoding a GFP marker and
expression constructs encoding the indi-
cated ataxin-3 proteins. The percentage of
cell death was determined 48 hr after trans-
fection (left panel); data are means from a
representative experiment done in dupli-
cates.
(B) Nuclear morphology of striatal neurons
expressing HA±Q79 and comparison of Bcl-2
protection against Q79 and serum with-
drawal±induced cell death. Striatal neurons
were transfected with HA±Q79/GFP or HA±
Q79/Bcl-2/GFP in the presence of serum or
Bcl-2/GFP in the absence of serum and
stained with Hoechst dye. The neuron ex-
pressing HA±Q79 showed cell body shrink-
age and nuclear condensation (arrow) The
neuron expressing both HA±Q79 and Bcl-2
showed normal cell body and nuclear size,
as well as neurites. The neuron expressing
Bcl-2 in the absence of serum showed normal
cell body and nuclear size but without neu-
rites.
(C) Prevention of Q79-induced cell death in
primary neurons by coexpression of CrmA,
FADD DN, Bcl-2, or Bcl-xL but not N-Bcl-xL.
Primary cerebellar neurons (upper panel), or
cerebellar, striatal, or cortical neurons (lower
panel), were transfected with vectors encod-
ing GFP and Q79 as well as with expression
constructs encoding either CrmA, FADD DN,
Bcl-2, Bcl-xL, or N-Bcl-xL in the presence or
absence of zVAD.fmk. Cell death was quanti-
tated 48 hr after transfection. Data are means
from a representative experiment done in du-
plicate. The experiments were repeated at
least twice with similar results.
(D) Fluorescence photomicrographs of pri-
mary cerebellar (left panels) or striatal (right
panels) neurons 48 hr after transfection with
both the GFP vector and the indicated combi-
nations of expression constructs encoding
Q79, CrmA, and FADD DN.
(E) Induction of apoptosis in HeLa cells by Q79 and its inhibition by CrmA, FADD DN, Bcl-2, and Bcl-xL. HeLa cells were transfected with the
GFP vector and either with expression constructs encoding Q79 or Q35 (left panel) or with the Q79 vector and constructs encoding CrmA,
FADD DN, Bcl-2, Bcl-xL, or N-Bcl-xL as indicated (middle panel). The right panel is a comparison of the effect of N-terminal-tagged Bcl-xL in
cell death induced by Q79 and tBid. The percentage of cell death was determined 48 hr after transfection. Data are mean 6 SD from one
representive experiment out of four similar experiments.
previously shown (Li et al., 1998), N-terminal-tagged in this process. Because in vitro kinetic analyses re-
vealed that CrmA inhibits caspase-1 and caspase-8Bcl-xL inhibited cell death induced by truncated Bid very
efficiently, it did not prevent Q79-induced cell death most potently (Zhou et al., 1997), with its effects on
caspases-3, 26, and 27 requiring concentrations sev-(Figure 1E, right panel). These data suggest that the
biochemistry of polyglutamine repeat±induced cell death eral orders of magnitude greater than those effective
for caspases-1 and 28 (rendering caspase-3, 26, andin HeLa cells is similar to that in primary cultured neu-
rons, thus validating the use of HeLa cells as a model 27 physiologically irrelevant targets for CrmA), our data
implicated caspase-1 or caspase-8 in polyglutamine re-system for further biochemical characterization of this
process. peat±induced cell death.
To investigate further the role of caspase-1 in cell
death induced by polyglutamine inclusions, we trans-Requirement of Caspase-8 Activity for Polyglutamine
Repeat±Induced Cell Death fected mouse embryonic fibroblasts that lack caspase-1
(caspase-12/2) with the Q79 vector. The extent of Q79-The inhibition of polyglutamine repeat±induced cell
death by CrmA and zVAD suggested a role for caspases induced cell death in caspase-12/2 cells did not differ
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significantly from that observed in the corresponding
wild-type (caspase-11/1) cells (Figure 2A, left panel), in-
dicating that caspase-1 is not required for polygluta-
mine-induced cell death. Similarly, the sensitivity of em-
bryonic fibroblasts that lack caspase-2 or caspase-11
to Q79-induced cell death was similar to that of wild-
type cells (Figure 2A, left panel), suggesting that these
two caspases also do not play a critical role in this
process. Furthermore, MCF7 cells, which do not express
caspase-3 (Janicke et al., 1998), are equally susceptible
to Q79-induced cell death (Figure 2A, middle panel),
suggesting that caspase-3 is also not essential for poly-
glutamine repeat±induced death.
A mutant Jurkat cell line specifically lacking caspase-8
was generated by ethylmethane sulfonate±induced mu-
tagenesis (Juo et al., 1998). We transfected the parental
and caspase-8 mutant Jurkat cells with the Q79 con-
struct and determined the percentage of cell death on
the basis of propidium iodide uptake. Whereas the wild-
type Jurkat cells were sensitive to Q79-induced cell
death, the caspase-8 mutant cells were resistant (Figure
2A, right panel), suggesting caspase-8 is critical for poly-
glutamine repeat±induced cell death. The role of cas-
pase-8 in polyglutamine-induced cell death was further
investigated in Jurkat cells transfected with a construct
encoding a dominant-negative mutant of caspase-8
(C360S), in which the cysteine residue from the active
site is replaced by serine, which inhibits apoptosis in-
duced by Fas or tumor necrosis factor (Vincenz and
Dixit, 1997). Expression of caspase-8 C360S inhibited
Q79-induced cell death in the wild-type Jurkat cells but
did not further reduce the cell death in caspase-8 mutant
Jurkat cells (Figure 2A, right panel). These results indi-
cate that inhibition of caspase-8 activity, either by a loss-
of-function mutation or by expression of a dominant-
negative mutant, results in inhibition of polyglutamine
repeat±induced cell death. In addition, our data suggest
that the dominant-negative caspase-8 mutant specifi-
cally inhibits caspase-8, since caspase-8 C360S had no
effect in caspase-8 mutant cells.
To determine whether polyglutamine-induced death
Figure 2. Requirement of Caspase-8 for Polyglutamine Repeat±of primary neurons also requires caspase-8 activity, we
Induced Cell Deathcotransfected cerebellar, striatal, and cortical neurons
(A) Embryonic fibroblasts (EF cells) that lack caspases-1, 22, orwith the vectors encoding Q79 and the dominant-nega-
211 or wild-type control cells (left panel), MCF7 cells (which lack
tive caspase-8 C360S mutant. Expression of caspase-8 caspase-3) (middle panel), and Jurkat cells (right panel) were trans-
C360S inhibited Q79-induced death in all three types of fected with the vectors encoding GFP and Q79 (in the absence or
neurons (Figure 2B). Together, these results indicate presence of a vector encoding the caspase-8 mutant C360S in the
case of Jurkat cells). The percentage of cell death was determinedthat caspase-8 is required for polyglutamine repeat±
48 hr after transfection. Data are means from a representative exper-induced neuronal cell death.
iment; p . 0.05 (pound sign), p , 0.05 (asterisk) versus correspond-
ing control cells (Student's t test). Cells lacking procaspase-8 or
expressing caspase-8 C360S but not cells mutant for caspase-1,
Caspase-8 Recruitment and Activation -2, -3, or -11 were resistant to expression of Q79.
(B) Rat (E17) primary neurons were transfected with vectors encod-by Polyglutamine Repeats
ing GFP and either Q79 or caspase-8 C360S (or both) as indicated,We next investigated the mechanism of caspase-8 acti-
and 48 hr after transfection, the percentage of cell death was deter-vation by polyglutamine repeats. Given that oligomeriza-
mined. Data are mean 6 SD from three experiments; p , 0.05
tion of caspase-8 is sufficient to induce its activation (asterisk) versus Q79 alone (Student's t test). The dominant-negative
(Yang et al., 1998), it was possible that polyglutamine mutant of caspase-8 C360S was able to block Q79-induced cell
repeats provide a surface for protein±protein interaction death in different populations of neurons.
and recruit caspase-8 directly or indirectly. To determine
whether Q79 recruits caspase-8, we examined the effect
of Q79 expression on the intracellular localization of a GFP±caspase-8 C360S vector (0.3 mg per well in a 6-well
GFP-tagged version of caspase-8 C360S in 293T cells. dish), the encoded protein was distributed evenly through-
out the cytoplasm (Figure 3A). In cells also transfectedIn cells transfected only with a low concentration of the
Caspase-8 and Polyglutamine-Induced Cell Death
627
Figure 3. Recruitment and Activation of Cas-
pase-8 by Polyglutamine Repeats
(A) 293T cells were transfected with a vector
encoding GFP-tagged caspase-8 C360S in
the absence (right panel) or presence (left
panel) of a vector encoding HA-tagged Q79.
The subcellular distribution of the caspase-8
mutant was subsequently examined by GFP
immunofluorescence analysis.
(B) HeLa cells were transfected (or not) with
a Q79 vector in the absence or presence of
100 mM zVAD. After continued incubation of
cells in the absence or presence of zVAD for
48 hr, the distribution and activation of cas-
pase-8 were examined by immunoblot analy-
sis of soluble (s) and insoluble (p) subcellular
fractions with a mAb to caspase-8 (a-casp-
8). The positions of 55, 46, and 20 kDa immu-
noreactive bands are indicated.
(C) HeLa cells were transfected with the Q79
expression vector and incubated in the ab-
sence or presence of zVAD as in (B), after
which the percentage of cell death was deter-
mined. Data are mean 6 SD of two experi-
ments.
(D) Striatal neurons were transfected with a vector encoding GFP-tagged caspase-8 C360S in the absence or presence of HA-tagged Q79 in
the presence of 100 mM zVAD. The subcellular localization of polyglutamine inclusions and the caspase-8 mutant were subsequently detected
by immunostaining with a mAb to HA and GFP fluorescence, respectively. Caspase-8 C360S colocalized with polyglutamine inclusions.
(E) Striatal neurons were transfected with a control vector or a vector encoding a C-terminal GFP-tagged Q79 in the presence of 100 mM
ZVAD, and the subcellular distributions of endogenous caspase-8 and Q79 were examined by immunostaining with a mAb to caspase-8 and
GFP fluorescence, respectively. Endogenous caspase-8 was recruited to the Q79 inclusions present in the cell body and neurite (arrow).
with a construct encoding Q79 tagged with the hemag- polyglutamine inclusions in neurons, we transfected
cultured striatal neurons with vectors encoding GFP-glutinin-epitope, GFP-caspase-8 C360S formed aggre-
gates that closely resembled Q79 inclusions (Figure 3A), tagged caspase-8 C360S and HA-tagged Q79. We
chose to use caspase-8 C360S here, because it onlysuggesting that caspase-8 is recruited by polyglutamine
repeats. differs from wild-type caspase-8 by one amino acid
change at the active site that renders it inactive andTo determine whether endogenous caspase-8 is re-
cruited by polyglutamine repeats, we examined the dis- unable to induce cell death, unlike the wild-type cas-
pase-8. GFP fluorescence revealed that the tagged cas-tribution of the endogenous protein in HeLa cells ex-
pressing Q79. Since overexpression of Q79 results in pase-8 mutant colocalized with the polyglutamine inclu-
sions (Figure 3D), indicating that GFP±caspase-8 C360Sformation of insoluble inclusions, we reasoned that if
caspase-8 is recruited by such inclusions, it would likely was recruited by these inclusions.
The possible recruitment of endogenous caspase-8exhibit a shift in subcellular distribution from the soluble
fraction to the insoluble fraction. We thus subjected the by polyglutamine inclusions in neurons was examined
by immunofluorescence analysis of primary striatal neu-soluble and insoluble fractions of control cells and of
cells expressing Q79 to Western blot analysis with a rons with the mAb to caspase-8. In control striatal neu-
rons, caspase-8 immunoreactivity was evenly distributedmonoclonal antibody to caspase-8. In control cells, cas-
pase-8 was present mostly in the soluble fraction, throughout the cytoplasm; however, in neurons express-
ing GFP-tagged Q79, caspase-8 appeared highly aggre-whereas in cells expressing Q79, it was recruited to
the insoluble fraction (Figure 3B). Caspase-8 was also gated at the sites of polyglutamine inclusions (Figure
3E). The polyglutamine inclusions were detected aroundactivated in cells expressing Q79, but not in control
cells, as indicated by the appearance of 46 and 20 kDa or within nuclei as well as in neuronal processes (Figure
3E), similar to the pattern observed in affected neuronsanti-caspase-8 immunoreactive bands that are the re-
ported molecular weights of activated caspase-8 sub- in brain tissue from individuals with HD (DiFiglia et al.,
units (Martin et al., 1998), in addition to the 55 kDa 1997). These observations indicate that endogenous
proenzyme. Activation of caspase-8, but not its recruit- caspase-8 is recruited by polyglutamine inclusions in
ment into the insoluble fraction in the Q79-expressing neurons and that such recruitment may result in the
cells, was prevented by performing transfection and activation of caspase-8.
subsequent incubation in the presence of zVAD (Figure
3B). The caspase inhibitor also suppressed Q79-induced
death in HeLa cells (Figure 3C). Thus, caspase-8 is acti- Inhibition of Polyglutamine-Mediated Caspase-8
Recruitment by Bcl-2, CrmA, or FADD DNvated in cells expressing Q79, and inhibition of caspase-8
activation prevented polyglutamine repeat±induced cell The mechanisms by which Bcl-2, CrmA, and FADD DN
inhibit polyglutamine repeat±induced cell death weredeath.
To investigate whether caspase-8 colocalizes with investigated by first examining the possibility that these
Neuron
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Figure 4. Inhibition of Polyglutamine Repeat±Mediated Recruitment of Caspase-8 by Bcl-2, CrmA, and FADD DN
(A) 293T cells were transfected with a vector encoding GFP-tagged Q79 in the absence or presence of vectors encoding caspase-8 C360S,
Bcl-2, N-Bcl-xL, CrmA, or FADD DN. Forty-eight hours after transfection, the percentage of cells containing polyglutamine inclusions was
determined by GFP fluorescence. Data are means from a representative experiment. The formation of polyglutamine inclusions was unaffected
by cotransfection with Bcl-2, CrmA, or FADD DN.
(B and C) 293T cells were transfected with a vector encoding GFP-tagged caspase-8 C360S in the absence or presence of vectors encoding
HA-tagged Q79, Bcl-2, N-Bcl-xL, CrmA, or FADD DN, as indicated. The number of cells containing GFP-positive inclusions was examined by
fluorescence microscopy (C) and quantitated (B). Caspase-8 C360S was recruited to Q79 inclusions, while it remained cytoplasmic when
coexpressed with Bcl-2, CrmA, or FADD DN but not N-tagged Bcl-xL (N-Bcl-xL).
(D) HeLa cells were transfected with a Q79 vector in the absence or presence of vectors encoding Bcl-2, N-Bcl-xL, or CrmA. The soluble (s)
and insoluble (p) fractions of cell lysates were subsequently subjected to immunoblot analysis with a mAb to caspase-8 (upper panel, arrow)
or with antibodies to caspase-3 (lower panel, arrow). In control HeLa cells as well as HeLa cells coexpressing Q79 and Bcl-2 or CrmA but
not N-Bcl-xL, endogenous caspase-8 is present in the soluble fraction, whereas in HeLa cells expressing Q79 alone, caspase-8 is present in
the insoluble fraction. Expression of Q79 also induced caspase-3 activation, as shown by the disappearance of the proform (arrow); however,
caspase-3 was not recruited into insoluble fractions when its activation was inhibited by zVAD. The top band in the caspase-3 Western blot
is an unrelated cross-immunoreactive protein shown here as an internal loading control.
anti-apoptotic proteins prevent the formation of polyglu- each of the test proteins. Subsequent quantitation of
inclusions containing the GFP-tagged caspase-8 mu-tamine inclusions. We thus transfected 293T cells with
a vector encoding GFP-tagged Q79 in the absence or tant revealed that Bcl-2, CrmA, and FADD DN, but not
N-Bcl-xL, prevented the formation of caspase-8 aggre-presence of vectors encoding the test proteins and sub-
sequently determined the percentage of cells containing gates in the presence of Q79 (Figures 4B and 4C). These
results suggest that the recruitment of caspase-8 is criti-inclusions. We chose 293T cells for these experiments,
because they express the SV40 large T antigen and cal for the induction of cell death by polyglutamine re-
peats.contain only a low concentration of caspase-8, and the
resulting delay in Q79-induced cell death allows the To examine whether prevention of recruitment of en-
dogenous caspase-8 underlies the ability of Bcl-2frequency of inclusion formation to be assessed before
cell death occurs. The percentage of cells containing and CrmA to inhibit polyglutamine repeat±induced cell
death, we determined the distribution of endogenousinclusions was not affected by Bcl-2, CrmA, or FADD
DN; similarly, caspase-8 C360S and N-Bcl-xL had no caspase-8 in HeLa cells expressing Q79 in the absence
or presence of an inhibitor. Western blot analysis witheffect on this parameter (Figure 4A). Thus, CrmA, Bcl-2,
and FADD DN must inhibit a step in polyglutamine- the mAb to caspase-8 revealed that caspase-8 was
present mostly in the soluble fractions of control cellsinduced cell death other than inclusion formation.
To examine whether Bcl-2, CrmA, or FADD DN inhibit and of cells coexpressing Q79 with Bcl-2 or CrmA,
whereas it was localized predominantly in the insolublethe recruitment of caspase-8 by polyglutamine inclu-
sions, we cotransfected 293T cells with vectors encod- fractions of cells expressing Q79 alone and of those
coexpressing Q79 and N-Bcl-xL (Figure 4D). In contrast,ing GFP-tagged caspase-8 C360S, HA-tagged Q79, and
Caspase-8 and Polyglutamine-Induced Cell Death
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Figure 6. Recruitment and Activation of Caspase-8 in Caudate Tis-
sue from Individuals with HD
The insoluble fractions of caudate tissue from four different HD
patients and five age-matched neurologically unremarkable individ-
uals (control) were subjected to immunoblot analysis with a mAb to
caspase-8 (upper left panel). Anti-caspase-8 immunoreactive bands
of z46 kDa were detected in HD samples that were similar in molecu-
lar weight to the activated caspase-8 in the insoluble fraction of
HeLa cells expressing Q79 (right panel). Antibodies to tubulin were
used to confirm that similar amounts of protein were loaded in each
lane (lower left panel).
vector and subsequently subjected soluble and insolu-
Figure 5. Recruitment of FADD DN, but Not of Bcl-2, by Polygluta-
ble fractions of cell lysates to Western blot analysismine Repeats
with a mAb to AU1 (Figure 5A). Whereas FADD DN was(A) HeLa cells were transfected with vectors encoding either AU1-
localized predominantly to the soluble fraction whentagged FADD DN or Bcl-2 in the absence or presence of a Q79
expressed by itself, a substantial portion of the proteinvector, as indicated. Soluble (s) and insoluble (p) fractions of cell
lysates were subsequently subjected to immunoblot analysis with was present in the insoluble fraction of cells also ex-
antibodies to AU1 or Bcl-2, as indicated. pressing Q79, suggesting that Q79 is able to recruit
(B) HeLa cells expressing GFP and HA-Q79 (GFP/Q79), GFP-tagged FADD DN. A similar experiment revealed that Bcl-2 was
Q79 (Q79±GFP), GFP-tagged FADD DN (GFP±FADD DN), or GFP±
not recruited by Q79 (Figure 5A).FADD DN and Q79 (GFP±FADD DN/Q79) were visualized by fluores-
The recruitment of FADD DN by Q79 was also appar-cence microscopy 24 hr after the transfection.
ent in 293T cells expressing GFP-tagged FADD DN and(C) HeLa cells expressing HA-tagged Q79 and AU1-tagged FADD
DN (24 hr after the transfection) were immunostained with antibodies Q79. Consistent with previous observations (Perez and
to HA and AU1 and examined by confocal microscopy; nuclear White, 1998), we showed that GFP-tagged FADD DN is
morphology was also revealed by staining with Hoechst dye. diffusely distributed within the cytoplasm and nucleus
of cells not expressing Q79 (Figure 5B). However, coex-
pression of FADD DN with Q79 resulted in the formation
caspase-3 was largely restricted to the soluble fractions of FADD DN aggregates (Figure 5B). To determine
of both control and Q79-expressing cells (Figure 4D). whether FADD DN colocalizes with Q79 inclusions, we
These results indicate that expression of Q79 recruits examined the localizations of HA-tagged Q79 and AU1-
caspase-8 to the insoluble fraction and that inhibition tagged FADD DN in transfected HeLa cells by immuno-
of Q79-induced cell death by Bcl-2, CrmA, or FADD DN cytochemistry and confocal microscopy. A substantial
may be related to the prevention of such caspase-8 portion of AU1-tagged FADD DN colocalized with the
recruitment. polyglutamine inclusions. These results suggest that
polyglutamine inclusions are able to recruit FADD DN
by interacting with its death domain and that such inter-Recruitment of FADD DN by Polyglutamine Repeats
Inhibition of polyglutamine repeat±induced cell death action may inhibit the recruitment of cell death±inducing
proteins.by FADD DN (Figure 1) suggests that the Fas pathway
contributes to this process. To examine the possible
role of extracellular signaling via the Fas pathway, we Detection of Caspase-8-Like Immunoreactivity
in the Insoluble Fraction of Affected Braininvestigated the effect of a neutralizing monoclonal
antibody to Fas ligand (NOK-1, Pharmingen) on Q79- Regions from HD Patients
Finally, we investigated whether recruitment of caspase-8induced cell death. This antibody had no effect on Q79-
induced HeLa cell death at a concentration of 1 mg/ml by polyglutamine inclusions could be detected in post-
mortem brain tissue from individuals with HD. We thus(data not shown), which is twice the concentration pre-
viously shown to be sufficient to inhibit Fas ligand± determined the distribution of caspase-8 between solu-
ble and insoluble fractions of caudate nuclei. In four outinduced apoptosis (Kayagaki et al., 1995; Oyaizu et al.,
1997). Thus, extracellular signaling via the Fas pathway of four caudate samples from HD patients, but in none
of the five samples from neurologically unremarkableis not involved in polyglutamine inclusion±induced cell
death. control individuals, we detected one or two bands of
z46 kDa in the insoluble fraction that reacted with theThe mechanism by which FADD DN inhibits Q79-
induced cell death was further investigated by examin- mAb to caspase-8; these proteins were similar in size
to activated caspase-8 in the insoluble fraction of HeLaing the subcellular localization of FADD DN in HeLa and
293T cells in the absence or presence of Q79 expression. cells expressing Q79 (Figure 6). In four out of four HD
cerebellum samples, which are unaffected in HD, weWe transfected HeLa cells with a vector encoding AU1-
tagged FADD DN in the absence or presence of a Q79 did not detect similar caspase-8-like immunoreactivity
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in the insoluble fraction (data not shown). In addition, accumulation of the corresponding truncated protein.
The mechanism responsible for the generation of thethe amount of caspase-8-like immunoreactivity in HD
caudate samples was markedly greater than that in con- truncated protein in each disease also may underlie the
tissue and cell-type specificity of neuronal degenera-trol caudate tissue, although no substantial difference
was apparent between the soluble fractions of HD and tion; that is, the specific conditions required for cleavage
of the disease-associated protein may be present onlycontrol caudate samples (I. S. and J. Y., unpublished
data). These preliminary results suggest that caspase-8 in the neuronal populations affected in each disease.
Although polyglutamine inclusions are detected only inor a related caspase-8-like protein is specifically re-
cruited to insoluble components of human caudate cells specific populations of vulnerable neurons in patients
with disease, other cell types are also sensitive to poly-and subsequently becomes activated.
glutamine repeat±induced cell death when forced to ex-
press a truncated protein containing such repeats. A
second possible rate-limiting factor may be the availabil-Discussion
ity of appropriate caspases. We propose that the pres-
ence of polyglutamine repeats in the nucleus may playThe mechanism of caspase activation has been the sub-
ject of intensive study. Activation of caspase-8 can be a role in the amplification of the apoptotic response,
including the induction of caspase-8 or reduction ofachieved through FK506 binding protein± (FKBP-) medi-
ated dimerization of an FKBP±caspase-8 fusion protein caspase-8 degradation during decades of disease incu-
bation period.(Muzio et al., 1998; Yang et al., 1998), These observa-
tions suggest that oligomerization of caspase-8 is suffi- Two inhibitors of caspase-8 recruitment, CrmA and
FADD DN, appear to act by distinct mechanisms. Be-cient to induce its activation. In contrast, caspase-3,
which contains a much shorter prodomain, cannot be cause CrmA is a pseudosubstrate type of inhibitor of
caspases, forming a tight complex with these enzymesactivated by a similar mechanism (Yang et al., 1998). To
date, Fas-induced apoptosis has been the only physio- (Komiyama et al., 1994), CrmA likely interacts directly
with caspase-8 to block its recruitment. The size of CrmAlogical process in which the recruitment and activation
of caspase-8 have been demonstrated. Polyglutamine may be critical here, since zVAD.fmk, which is also a
pseudosubstrate inhibitor, did not inhibit the recruitmentrepeats may promote a pathological mechanism of
protein±protein interaction that results in the recruitment of caspase-8. In fact, full-length caspase-8 has been
shown to interact with CrmA (Muzio et al., 1998). Inand activation of caspase-8. We have shown here that
caspase-8 is likely to be recruited and activated specifi- contrast, FADD DN may interact directly with polyglu-
tamine repeats and thereby prevent the recruitment ofcally in the caudate nuclei of HD patients, suggesting
that the recruitment and activation of caspase-8 may caspase-8. FADD DN consists predominantly of a death
domain that interacts homophilically with the death do-be responsible for neuronal degeneration in HD. The
mutant polyglutamine repeat±containing proteins have main of the Fas receptor. Although the mechanism by
which caspase-8 is recruited to polyglutamine repeatsbeen shown to recruit a number of proteins, including
proteins involved in ubiquitination (Davies et al., 1997; remains unclear, we hypothesize that an adapter protein
similar to FADD, which contains a death domain and aGourfinkel-An et al., 1998) and molecular chaperone
HDJ-2 (HSDJ) (Cummings et al., 1998). Of all the known death effector domain, may act as a bridge between the
polyglutamine repeats and caspase-8. Our data thusproteins recruited by polyglutamine repeats, none is po-
tentially more dangerous to the cell than caspase-8, suggest that an alternative intracellular Fas pathway
plays a critical role in mediating neuronal degenerationwhich can trigger the activation of downstream compo-
nents of the apoptotic pathway and neuronal cell death. induced by polyglutamine inclusions and that inhibition
of the recruitment of caspase-8 may be able to preventAlthough our data appear to rule out the recruitment
of caspases, such as caspase-3, that contain a short or retard the progression of neuronal loss in polygluta-
mine expansion diseases.prodomain, it remains to be examined whether other
caspases with a long prodomain are also recruited by We have shown that polyglutamine repeat±induced
cell death is inhibited by expression of Bcl-2 or Bcl-polyglutamine inclusions.
Apoptosis induced by oligomerization and activation xL but not N-Bcl-xL. Expression of Bcl-2 or Bcl-xL has
previously been shown to inhibit apoptosis induced byof caspase-8 requires only hours (Muzio et al., 1998;
Yang et al., 1998), whereas neurodegenerative diseases a wide variety of stimuli. Two major mechanisms have
been proposed to explain the actions of Bcl-2 and Bcl-such as HD develop over decades. Various rate-limiting
factors may contribute to this apparent discrepancy. xL, based on the observations that these proteins form
ion channels (Minn et al., 1997; Schendel et al., 1997)The first and most important rate-limiting factor is the
generation of a truncated protein consisting predomi- or interact directly with other mediators of apoptosis,
such as CED-4 and Apaf-1 (Chinnaiyan et al., 1997; Pannantly of polyglutamine repeats. Expression of full-
length huntingtin or related proteins such as ataxin-3, et al., 1998). Although it is not clear whether these two
modes of action coexist, a free N terminus of Bcl-xL isregardless of the length of the polyglutamine repeat, is
not toxic to cells, whereas truncated versions of these required for the protein to protect cells from apoptosis
only in certain instances. We have recently shown thatproteins containing a sufficient number of polyglutamine
repeats are highly cytotoxic (Goldberg et al., 1996; Mi- Bid, a proapoptotic member of the Bcl-2 family, be-
comes a potent inducer of apoptosis after cleavage byyashita et al., 1997; Wellington et al., 1998; the present
study). The decades required for these diseases to de- caspase-8 (Li et al., 1998). Whereas an N-terminally
tagged form of Bcl-xL was highly efficient in inhibitingvelop may thus reflect the time required for sufficient
Caspase-8 and Polyglutamine-Induced Cell Death
631
cell death induced by truncated Bid, it could not inhibit stress-related proteins, such as members of the Bcl-2
polyglutamine repeat±induced cell death. A free N termi- and c-Jun N-terminal kinase (JNK) families, but not
nus of Bcl-xL is required for its biochemical and func- enough to kill, since caspases are not activated; eventu-
tional interaction with CED-4 and the CED-4-like domain ally, however, the stress response system may be over-
in Apaf-1 (Chinnaiyan et al., 1997; Pan et al., 1998); our whelmed, and an apoptotic response, which could in-
results suggest that a similar interaction may be required clude upregulation of caspases or reduction of caspase
for Bcl-xL to inhibit polyglutamine inclusion±induced cell turnover, may ensue. Such upregulation of pro- and anti-
death. Since caspase-8 can interact with both Apaf-1 apoptotic proteins, such as bad, bax, and bcl-2, have
(Hu et al., 1998) and Bcl-xL (Chinnaiyan et al., 1997), the been demonstrated in human tissues affected with other
competition between caspase-8 binding to Apaf-1 and neurodegenerative diseases (Kitamura et al., 1998). This
Bcl-xL has been hypothesized to play a role in mediating scenario may be consistent with the apparent induction
caspase-8 activation. We suggest that Bcl-xL may inhibit of caspase-8-like immunoreactivity in caudate tissue
polyglutamine repeat±induced cell death by competing from HD patients. The levels of caspase-8 in control
for binding of caspase-8. caudate tissue are low compared with that in HeLa,
Studies with transgenic mice expressing exon 1 of Jurkat, and MCF7 cells (I. S. and J. Y., unpublished
the huntingtin gene and mutant SCA1 as well as with data), whereas the amount of caspase-8 in the insoluble
brain tissue from patients with SCA3 or HD have shown fraction of HD caudate tissue is markedly increased.
that expanded polyglutamine repeats can form aggre- Such upregulation of caspase-8 may be required for
gates within nuclei (Davies et al., 1997; DiFiglia et al., recruitment and activation of caspase-8 by cytoplasmic
1997; Paulson et al., 1997). These observations have led polyglutamine repeats. After such cytoplasmic activa-
to the hypothesis that the formation of such intranuclear tion, caspase-8 may enter the nucleus, together with
inclusions is a critical step in neuronal degeneration. other downstream caspases, to complete the apoptotic
Recently, however, two groups have provided evidence process.
against a critical role of intranuclear inclusions in induc-
ing neurodegeneration (Klement et al., 1998; Saudou et
Concluding Remarksal., 1998). Our study does not directly address the role of
We have shown here that the recruitment of caspase-8inclusions, since induction of caspase-8 oligomerization
by polyglutamine repeats may contribute to the patho-by polyglutamine repeats may not require the formation
genesis of HD and related diseases. We suggest thatof microscopically visible inclusions. The system used
such recruitment may not be limited to HD-related neu-by Saudou et al. (1998) is similar to ours, except that they
rodegenerative disorders. Formation of intracellular ag-used a long version of huntingtin (amino acids 1±480 of
gregates occurs in several other diseases, as exempli-huntingtin) that may need to be further cleaved to acti-
fied by the Lewy bodies associated with Parkinson'svate cell death, explaining a delay of up to 9 days before
disease and the recent demonstration of aggregatesinducing cell death; in contrast, we used a construct
of an amyotrophic lateral sclerosis±associated mutantexpressing a polyglutamine repeat only, and cell death
form of superoxide dismutase in transgenic mice (Bruijncan be induced directly by this peptide without further
et al., 1998). Given that oligomerization may be a funda-cleavage.
mental mechanism of caspase activation, other intracel-Although our data do not distinguish between the
lular aggregates with properties similar to those of poly-roles of nuclear versus cytoplasmic repeats, we pro-
glutamine inclusions also might be able to recruit andpose that caspase-8 recruitment by such repeats occurs
activate caspases and induce cell death.predominantly within the cytoplasm for the following
reasons: first, caspase-8 is normally localized in the
cytoplasm rather than in nuclei, and second, most Experimental Procedures
anti-apoptotic proteins, including Bcl-2 and Bcl-xL, nor-
Plasmid Constructionmally reside on the outer mitochondrial membrane
A cDNA encoding the GFP-tagged C360S mutant of caspase-8 was(Merry and Korsmeyer, 1997). Thus, we suggest that
constructed by digesting a caspase-8 C360S expression constructrecruitment and activation of caspase-8, as well as inhi- (kindly provided by V. Dixit) with KpnI and XhoI and cloning the
bition of caspase-8 by Bcl-2 and Bcl-xL, occur primarily released fragment into pEGFP-N2 (Clontech). The caspase-8 read-
in the cytoplasm. In addition, although most caspase-8 ing frame (lacking the sequence encoding 45 amino acids of the
molecules appeared to be associated with the Q79 inclu- small subunit at the C terminus) was thus placed in the reverse
orientation but within appropriate restriction sites. The resultingsions, we cannot rule out the possibility that the interac-
plasmid was digested with BamHI and XhoI, and the released frag-tion of caspase-8 with the polyglutamine repeats occurs
ment was cloned into pEGFP-N2 that had been digested with BglIIbefore aggregate formation; aggregation of the polyglu-
and SalI. The resulting vector encodes caspase-8 C360S (lacking
tamine repeats may then simply serve to bring together 45 amino acids) fused at its C terminus with GFP. The vector encod-
multiple caspase-8 molecules. In the case of the Fas ing FADD DN fused at its C terminus with GFP was generated by
receptor, the interaction of two caspase-8 molecules is digesting a FADD expression construct (kindly provided by V. Dixit)
sufficient to induce their activation (Muzio et al., 1998; with SalI and BamHI and cloning the released fragment into pEGFP-
C1 (Clontech) that had been digested with the same two restrictionYang et al., 1998).
enzymes. The vector encoding Q79 fused at its C terminus with GFPIf the cytoplasmic polyglutamine repeats play a pri-
was prepared by digesting Q79-pIND with HindIII and ApaI andmary role in caspase recruitment and activation, what
cloning the released fragment into pEGFP-N2 that had been di-
then is the role of the intranuclear repeats? We propose gested with the same two enzymes. The Bcl-2 expression construct
that the presence of expanded polyglutamine repeats was RR/1 (Gagliardini et al., 1994). The construct encoding Bcl-xL
in the nucleus may be sufficient to induce a stress re- tagged at its N terminus with the Flag-epitope (N-Bcl-xL) was as
described by Li et al. (1998).sponse, which may initially result in the induction of
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